Literature DB >> 16326289

Disc regeneration: why, when, and how.

J C Lotz1, A J Kim.   

Abstract

There is increasing acknowledgment that patients with back pain who are candidates for surgery, will benefit over the long term from less invasive procedures that facilitate dynamic stabilization, rather than fusion. Dynamic stabilization can be addressed by providing assistance using mechanical devices, or relying on biologic processes such as tissue regeneration and repair. The concept of biologic disc repair has grown in recent years because of improved understanding of the cellular and molecular events of disc aging and degeneration. This article describes approaches to cell therapy, reviews relevant studies, and discusses ways to maximize clinical efficacy. Tissue engineering approaches for disc regeneration and healing have significant clinical potential.

Entities:  

Mesh:

Year:  2005        PMID: 16326289     DOI: 10.1016/j.nec.2005.06.004

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  7 in total

1.  Intervertebral discs from spinal nondeformity and deformity patients have different mechanical and matrix properties.

Authors:  Kevin K Cheng; Sigurd H Berven; Serena S Hu; Jeffrey C Lotz
Journal:  Spine J       Date:  2013-11-15       Impact factor: 4.166

2.  Methods to monitor distribution and metabolic activity of mesenchymal stem cells following in vivo injection into nucleotomized porcine intervertebral discs.

Authors:  G W Omlor; H Bertram; K Kleinschmidt; J Fischer; K Brohm; T Guehring; M Anton; Wiltrud Richter
Journal:  Eur Spine J       Date:  2009-12-29       Impact factor: 3.134

3.  Different Expression of Extracellular Matrix Genes : Primary vs. Recurrent Disc Herniation.

Authors:  Sung-Uk Kuh; Young-Min Kwon; Dong-Kyu Chin; Keun-Su Kim; Byung-Ho Jin; Yong-Eun Cho
Journal:  J Korean Neurosurg Soc       Date:  2010-01-31

4.  Evaluation criteria for musculoskeletal and craniofacial tissue engineering constructs: a conference report.

Authors: 
Journal:  Tissue Eng Part A       Date:  2008-12       Impact factor: 3.845

5.  The response of nucleus pulposus cell senescence to static and dynamic compressions in a disc organ culture.

Authors:  Jianmin Shi; Lianglong Pang; Shouguo Jiao
Journal:  Biosci Rep       Date:  2018-03-09       Impact factor: 3.840

6.  Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study.

Authors:  Christine L Le Maitre; Judith A Hoyland; Anthony J Freemont
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

7.  Resveratrol increases nucleus pulposus matrix synthesis through activating the PI3K/Akt signaling pathway under mechanical compression in a disc organ culture.

Authors:  Xiaorui Han; Xiaoming Leng; Man Zhao; Mei Wu; Amei Chen; Guoju Hong; Ping Sun
Journal:  Biosci Rep       Date:  2017-11-23       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.